Mayur Ian Somaiya

Companies

• NewAmsterdam Pharma Co N.V.Chief financial officer Dec 29, 2023 to now¹
• TCR2 THERAPEUTICS INC.Chief financial officer Feb 13, 2019 to Dec 16, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NPNewAmsterdam Pharma Co N.V. NAMS58,382 shares³$1.2M at $20.29Jan 21, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 21, 2026Sold 24,362 shares at $33.80 of NewAmsterdam Pharma Co N.V.³
• Jan 21, 2026Sold 15,422 shares at $33.25 of NewAmsterdam Pharma Co N.V.³
• Jan 21, 2026Exercised options 39,784 shares at $9.26 of NewAmsterdam Pharma Co N.V.³
• Jan 20, 2026Sold 19,604 shares at $32.38 of NewAmsterdam Pharma Co N.V.³
• Jan 20, 2026Sold 39,712 shares at $31.78 of NewAmsterdam Pharma Co N.V.³
• Jan 20, 2026Sold 900 shares at $30.64 of NewAmsterdam Pharma Co N.V.³
• Jan 20, 2026Exercised options 60,216 shares at $9.26 of NewAmsterdam Pharma Co N.V.³
• Jan 7, 2026Granted 25,500 shares of NewAmsterdam Pharma Co N.V.⁴
• Jan 5, 2026Sold 5,118 shares at $33.25 of NewAmsterdam Pharma Co N.V.⁴
• Jan 28, 2025Sold 3,405 shares of NewAmsterdam Pharma Co N.V.⁵
• Jan 28, 2025Sold 11,495 shares of NewAmsterdam Pharma Co N.V.⁵
• Jan 28, 2025Exercised options 14,900 shares at $9.26 of NewAmsterdam Pharma Co N.V.⁵
• Jan 27, 2025Sold 13,304 shares of NewAmsterdam Pharma Co N.V.⁵
• Jan 27, 2025Sold 33,679 shares of NewAmsterdam Pharma Co N.V.⁵
• Jan 27, 2025Exercised options 46,983 shares at $9.26 of NewAmsterdam Pharma Co N.V.⁵
• Jan 7, 2025Granted 38,000 shares of NewAmsterdam Pharma Co N.V.⁶